Your session is about to expire
← Back to Search
Behavioural Intervention
Immersive VR Training for Vision Impairment (Re:Garde Trial)
N/A
Recruiting
Led By Michael Reber, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
65 years of age or older
Be older than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up initial visit (day 1), mid-point (end of week 3), treatment completion (week 7)
Awards & highlights
Re:Garde Trial Summary
This trial looks at whether a virtual reality program can help seniors maintain or improve their vision and ability to do everyday activities, promoting quality of life and independence.
Who is the study for?
This trial is for older adults aged 65 or above with self-reported healthy vision or minor vision issues correctable with glasses/contacts. Participants must be able to use a VR headset and have Wi-Fi access at home. It's not suitable for those with medically diagnosed vision impairments, neck conditions, injuries that prevent VR use, or non-English speakers.Check my eligibility
What is being tested?
The Re:Garde Program uses immersive Virtual Reality (VR) to help seniors maintain visual perception. The study assesses if this program can improve daily living activities like reading and driving, overall wellness, and quality of life when used in a clinic or at home.See study design
What are the potential side effects?
While the trial primarily focuses on training visual perception using VR technology, potential side effects may include discomfort from wearing the headset, motion sickness from VR immersion, eye strain or fatigue due to prolonged usage.
Re:Garde Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am 65 years old or older.
Re:Garde Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ initial visit (day 1), mid-point (end of week 3), treatment completion (week 7)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~initial visit (day 1), mid-point (end of week 3), treatment completion (week 7)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Changes from baseline in self-reported independence/autonomy using the Instrumental Activities of Daily Living (IADL) Scale
Changes from baseline in self-reported vision based on the Activities of Daily Vision Scale (ADVS)
Changes from baseline in self-reported well-being using the World Health Organization-5 Well-Being Index (WHO-5)
+4 moreRe:Garde Trial Design
2Treatment groups
Experimental Treatment
Group I: Group B: Home SettingExperimental Treatment1 Intervention
Participants will complete their virtual reality (VR) visual training program from their own homes using a head-mounted display (HMD) that is on loan for the study. Participants will receive initial training on using the device and software at the clinic and will take home the HMD to complete their 6-weeks of visual training independently from home. Additional training and FAQ materials will be given to participants to use as reference.
Group II: Group A: Clinic SettingExperimental Treatment1 Intervention
Participants will complete their virtual reality (VR) visual training program by visiting a local clinic and using the head-mounted display (HMD) provided. Participants will receive initial training on using the device and software and are expected to complete their 6-weeks of visual training independently at the clinic. Additional training and FAQ materials will be available on site for participants to use as reference.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HMD: Immersive VR
2022
N/A
~10
Find a Location
Who is running the clinical trial?
University Health Network, TorontoLead Sponsor
1,472 Previous Clinical Trials
484,974 Total Patients Enrolled
1 Trials studying Visual Impairment
30 Patients Enrolled for Visual Impairment
Perley RideauUNKNOWN
Michael Reber, PhDPrincipal InvestigatorUniversity Health Network, Toronto
2 Previous Clinical Trials
80 Total Patients Enrolled
1 Trials studying Visual Impairment
30 Patients Enrolled for Visual Impairment
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I consider my vision to be healthy or have minor issues only.I am 65 years old or older.I have no neck injuries or face wounds that prevent using a VR headset.I have been diagnosed with a vision impairment by a doctor.
Research Study Groups:
This trial has the following groups:- Group 1: Group A: Clinic Setting
- Group 2: Group B: Home Setting
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are recruitment efforts still underway for this trial?
"According to the most recently updated information on clinicaltrials.gov, this trial is not actively seeking participants at present. Although initially posted in January of 2023, it was last edited in November 2022 and no longer requires new candidates. However, 53 other medical studies are currently recruiting patients across the country."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger